The first clinical trial investigating whether psilocybin, the psychedelic compound found in magic mushrooms, could treat Parkinson’s disease has yielded promising early-stage results. Scientists have described the findings as both
The first clinical trial investigating whether psilocybin, the psychedelic compound found in magic mushrooms, could treat Parkinson’s disease has yielded promising early-stage results. Scientists have described the findings as both
A groundbreaking clinical trial at University College London (UCL) is poising to transform the landscape of alcohol misuse treatment through the utilisation of dimethyltryptamine (DMT), a potent psychedelic compound. The






